DENVER, CO–(Marketwired – Feb 27, 2015) – Mountain High Acquisitions Corp. (OTCQB:MYHI) (“Mountain High” or the “Company”) is pleased to announce that GreenLife BotaniX, Inc. President, Brent McMahon will be interviewed by PotStockRadio on Sunday, March 1, 2015 from 8:30pm EST to 10:00pm EST. GreenLife BotaniX, Inc. (“GreenLife”) is a wholly-owned subsidiary of the Company.

In this exclusive interview, PotStockRadio host, Eric Butz and co-Hosts Ryan Godfrey and Chris Trace will chat with Brent McMahon about GreenLife’s rapidly growing “SuperCBD” hemp oil infused nutraceutical products business, their expansion strategy, and their recent acquisition by Mountain High. McMahon will also discuss Mountain High’s recent agreement to acquire Freedom Seed and Feed, Inc., the owner and operator of the first federally permitted hemp seed and fiber farm in the United States. Listeners will have the opportunity to have their questions answered live during the broadcast.

Brent McMahon, GreenLife BotaniX, Inc., President, said, “We are pleased to have been invited to be interviewed by PotStockRadio. I look forward to the opportunity to interact with listeners from around the world, and to discuss our world-class ‘SuperCBD’ hemp oil products and our planned strategic vertical combination with Mountain High and Freedom Seed and Feed.”

Tune in to PotStockRadio at:

Date: Sunday, March 1, 2015
Time: 8:30pm ET to 10:00pm ET
Link: https://potstockradio.com/potstockradio-com-mountain-high-acquisitions-myhi-greenlife-botanix-inc/
Twitter Hashtag: #potstockradio

If you have any questions for Brent McMahon that you would like answered during the interview, please email eric@potstockradio.com before Sunday, March 1, 2015, 4:00pm EST.

About GreenLife BotaniX, Inc.

GreenLife BotaniX, Inc. (“GreenLife”) (www.greenlifebotanix.com) is a California-based developer and marketer of CBD hemp oil infused nutraceutical products. GreenLife is focused on the development and sale of products containing and featuring non-psychoactive CBD (cannabidiol) derived from hemp oil and sold under the retail brand name “SuperCBD.” GreenLife currently offers over a dozen CBD-based products, including four primary products; “Super CBD Drops” — a high-potency vanilla flavored vegan hemp oil tincture, “Super CBD Lotion” — a CBD lotion made with a unique blend of CBD, eucalyptus oil, and vitamins and minerals, “Super CBD Lip Balm” — a medicated ointment intended for a variety of skin problems, cuts and rashes, and “Super CBD Pills” — a concentrated CBD dose in pill form for easy ingestion.

About Mountain High Acquisitions Corp. (MYHI)

Mountain High Acquisitions Corp. (www.mountainhighac.com) is a diversified holding company focused on the acquisition and development of businesses within the hemp and CBD nutraceutical sectors. The Company’s wholly owned subsidiary, GreenLife BotaniX, Inc. (www.greenlifebotanix.com), is a California-based developer and marketer of the “SuperCBD” brand of CBD hemp oil infused nutraceutical products.

Mountain High Acquisition Corp. files reports with the Securities and Exchange Commission. The Company’s SEC filings can be viewed at www.sec.gov.

Disclaimer/Safe Harbor: This Mountain High Acquisitions Corp. news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include failure to meet schedule or performance requirements of the Company’s contracts, the Company’s ability to raise sufficient development and working capital, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur as planned or at all. The Company does not and will not grow, harvest, distribute, or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.